TY - JOUR
T1 - Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients
AU - Hansen, C. R.
AU - Pressler, T.
AU - Nielsen, K. G.
AU - Jensen, Peter Østrup
AU - Bjarnsholt, Thomas
AU - Høiby, Niels
N1 - Keywords: Achromobacter denitrificans; Adolescent; Adult; Anti-Bacterial Agents; Biofilms; Breath Tests; Child; Cystic Fibrosis; Drug Resistance, Bacterial; Female; Forced Expiratory Volume; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Humans; Interferon-gamma; Interleukin-10; Interleukin-1beta; Interleukin-6; Interleukin-8; Male; Pneumonia, Bacterial; Retrospective Studies; Sputum; Tumor Necrosis Factor-alpha; Young Adult
PY - 2010/1/1
Y1 - 2010/1/1
N2 - Background: Achromobacter xylosoxidans infection may cause conspicuous chronic pulmonary inflammation in cystic fibrosis (CF) patients similar to Pseudomonas aeruginosa and the Burkholderia cepacia complex (Bcc). Evolution in lung function was compared in chronically infected patients. Cytokine concentrations in CF patients with and without chronic infection were compared to healthy controls. Methods: Cytokines in serum and sputum were measured using multiplex bead based immunoassay. Results: Sixty CF patients, 11 with A. xylosoxidans, 11 with Bcc, 21 with P. aeruginosa and 17 non-infected CF patients were compared to 11 healthy controls. A. xylosoxidans patients were younger, but had a FEV1 decline similar to P. aeruginosa patients. Bcc patients had the steepest decline in FEV1. Serum levels of G-CSF, IL-6 and TNF-α were significantly higher in CF patients compared to healthy controls. Chronically infected CF patients had significantly higher serum levels of IFN-γ and IL-6 compared to non-infected CF patients. Bcc patients had significantly lower serum G-CSF and A. xylosoxidans patients had significantly higher sputum TNF-α compared to the other groups of chronically infected patients. Conclusion: A. xylosoxidans can cause a level of inflammation similar to P. aeruginosa in chronically infected CF patients. A. xylosoxidans is a clinically important pathogen in CF and should be treated accordingly.
AB - Background: Achromobacter xylosoxidans infection may cause conspicuous chronic pulmonary inflammation in cystic fibrosis (CF) patients similar to Pseudomonas aeruginosa and the Burkholderia cepacia complex (Bcc). Evolution in lung function was compared in chronically infected patients. Cytokine concentrations in CF patients with and without chronic infection were compared to healthy controls. Methods: Cytokines in serum and sputum were measured using multiplex bead based immunoassay. Results: Sixty CF patients, 11 with A. xylosoxidans, 11 with Bcc, 21 with P. aeruginosa and 17 non-infected CF patients were compared to 11 healthy controls. A. xylosoxidans patients were younger, but had a FEV1 decline similar to P. aeruginosa patients. Bcc patients had the steepest decline in FEV1. Serum levels of G-CSF, IL-6 and TNF-α were significantly higher in CF patients compared to healthy controls. Chronically infected CF patients had significantly higher serum levels of IFN-γ and IL-6 compared to non-infected CF patients. Bcc patients had significantly lower serum G-CSF and A. xylosoxidans patients had significantly higher sputum TNF-α compared to the other groups of chronically infected patients. Conclusion: A. xylosoxidans can cause a level of inflammation similar to P. aeruginosa in chronically infected CF patients. A. xylosoxidans is a clinically important pathogen in CF and should be treated accordingly.
U2 - 10.1016/j.jcf.2009.10.005
DO - 10.1016/j.jcf.2009.10.005
M3 - Journal article
C2 - 19939747
SN - 1569-1993
VL - 9
SP - 51
EP - 58
JO - Journal of Cystic Fibrosis
JF - Journal of Cystic Fibrosis
IS - 1
ER -